Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 89.60B | 91.06B | 85.90B | 77.71B | 72.70B | 66.91B |
Gross Profit | 20.08B | 20.13B | 19.41B | 17.38B | 16.85B | 16.01B |
EBITDA | 2.70B | 2.57B | 2.94B | 1.77B | 2.32B | 2.13B |
Net Income | 1.22B | 1.05B | 1.34B | 358.19M | 798.55M | 858.21M |
Balance Sheet | ||||||
Total Assets | 24.90B | 24.08B | 23.65B | 22.02B | 21.38B | 19.22B |
Cash, Cash Equivalents and Short-Term Investments | 5.08B | 4.78B | 4.90B | 3.51B | 3.62B | 2.62B |
Total Debt | 3.19B | 3.34B | 3.73B | 4.81B | 4.43B | 3.45B |
Total Liabilities | 13.60B | 12.88B | 13.29B | 12.94B | 12.53B | 11.08B |
Stockholders Equity | 11.30B | 11.20B | 10.36B | 9.07B | 8.85B | 8.13B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.34B | 2.75B | 162.40M | 541.16M | 702.61M |
Operating Cash Flow | 0.00 | 1.90B | 3.46B | 1.28B | 1.56B | 1.66B |
Investing Cash Flow | 0.00 | -810.80M | -698.79M | -1.34B | -1.07B | -997.13M |
Financing Cash Flow | 0.00 | -1.21B | -1.37B | -47.35M | 526.74M | -1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.48B | 7.01 | 2.38% | 15.66% | 2.87% | ||
76 Outperform | ¥12.02B | 11.45 | 1.10% | 6.01% | -21.51% | ||
74 Outperform | ¥9.09B | 9.24 | 2.98% | 2.42% | 154.96% | ||
70 Outperform | ¥11.00B | 6.96 | 1.47% | 0.19% | 32.51% | ||
65 Neutral | $27.25B | 15.35 | -4.01% | 3.14% | 1.00% | 1.98% | |
54 Neutral | ¥12.72B | ― | 2.30% | 0.65% | -679.30% | ||
41 Neutral | ¥9.44B | ― | ― | -5.60% | -23.60% |